Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Description of key information

The 90 day repeat dose oral study gives NOAEL 3 mg / kg / day.
The 28 day repeat dose oral study gives NOAEL 5 mg / kg / day.
The repeat dose dermal and inhalation were waived on grounds of low toxicity.

Key value for chemical safety assessment

Repeated dose toxicity: via oral route - systemic effects

Endpoint conclusion
Dose descriptor:
NOAEL
3 mg/kg bw/day
Study duration:
subchronic
Species:
rat

Additional information

Justification for classification or non-classification

All physiological effects in the 28-day repeat dose toxicity study: oral, were completely reversible.

The 90-day repeat dose toxicty study: oral, did show foam cells in the alveoli of both sexes which can represent  phospholipidosis. However this was confined to rats and lungs at a high dose and is not considered to be an effect of importance.

Therefore under the conditions of these studies Evernox 1135 is not classified.